Welcome!
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.
In these videos, the panel discusses treatment options for a patient diagnosed with EGFR Exon 19 Deletion NSCLC and looks at data from the Laura Trial. They also discuss treatment options for a patient with a smoking history and diagnosis of small cell lung cancer, and how the Adriatic Study factors into decisions.
As part of the 2025 Blood Cancer Video Library, where oncologists discuss the most emerging treatment options and information in blood cancer, Dr. Shaji Kumar (Mayo Clinic) discusses optimal strategies for the treatment of newly diagnosed multiple myeloma (MM).
The journey to conquer lung cancer is paved with scientific discovery, and the identification of the EGFR and ALK genes as crucial players marks a significant milestone. Unraveling how mutations in these seemingly small segments of our DNA can unleash the destructive force of cancer has opened up exciting new therapeutic avenues. This exploration delves into the cutting-edge world of EGFR and ALK-targeted therapies, highlighting the progress made and the ongoing quest for even more effective and personalized strategies to combat this formidable disease.
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.